Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 15.7B | 16.7B | 15.1B | 14.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 5.5B | 6.0B | 5.4B | 5.4B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 5.5B | 6.4B | 5.2B | 5.4B |
| Tax provision | 1.1B | 1.3B | 993M | 887M |
| Net income | 4.4B | 5.1B | 4.2B | 4.5B |
| Basic EPS | 3.0 | 3.5 | — | 3.1 |
| Diluted EPS | 3.0 | 3.5 | — | 3.1 |
| Basic average shares | 1.4B | 1.4B | — | 1.4B |
| Diluted average shares | 1.4B | 1.4B | — | 1.4B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 4.4B | 5.1B | 4.2B | 4.5B |
| Minority interests | -4M | -2M | -3M | -3M |
| Preferred stock dividends | — | — | — | — |